Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study

Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 53; no. 3; pp. 881 - 888
Main Authors Park, Eun Ju, Park, Kwonoh, Kim, Jae-Joon, Oh, Sang-Bo, Jung, Ki Sun, Oh, So Yeon, Hong, Yun Jeong, Kim, Jin Hyeok, Jang, Joo Yeon, Jeon, Ung-Bae
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.07.2021
대한암학회
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2020.1008

Cover

Abstract Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.
AbstractList Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.
The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access. Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death). A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001). Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.
Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. KCI Citation Count: 0
The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.PURPOSEThe purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).MATERIALS AND METHODSTerminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001).RESULTSA total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001).Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.CONCLUSIONRoutine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.
Author Kim, Jae-Joon
Park, Kwonoh
Jung, Ki Sun
Jeon, Ung-Bae
Hong, Yun Jeong
Oh, Sang-Bo
Jang, Joo Yeon
Park, Eun Ju
Oh, So Yeon
Kim, Jin Hyeok
AuthorAffiliation 3 Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea
4 Department of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
2 Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
1 Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
AuthorAffiliation_xml – name: 4 Department of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
– name: 1 Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
– name: 2 Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
– name: 3 Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea
Author_xml – sequence: 1
  givenname: Eun Ju
  surname: Park
  fullname: Park, Eun Ju
– sequence: 2
  givenname: Kwonoh
  surname: Park
  fullname: Park, Kwonoh
– sequence: 3
  givenname: Jae-Joon
  surname: Kim
  fullname: Kim, Jae-Joon
– sequence: 4
  givenname: Sang-Bo
  surname: Oh
  fullname: Oh, Sang-Bo
– sequence: 5
  givenname: Ki Sun
  surname: Jung
  fullname: Jung, Ki Sun
– sequence: 6
  givenname: So Yeon
  surname: Oh
  fullname: Oh, So Yeon
– sequence: 7
  givenname: Yun Jeong
  surname: Hong
  fullname: Hong, Yun Jeong
– sequence: 8
  givenname: Jin Hyeok
  surname: Kim
  fullname: Kim, Jin Hyeok
– sequence: 9
  givenname: Joo Yeon
  surname: Jang
  fullname: Jang, Joo Yeon
– sequence: 10
  givenname: Ung-Bae
  surname: Jeon
  fullname: Jeon, Ung-Bae
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33355838$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738775$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kk1vEzEQhi1URNPCkSvyESQ2-Gs3aw5IUdTCSpWImvRsOd5ZYrrrDbZTFP5f_xfebFsBEqexZp55ZzR-z9CJ6x0g9JqSqaCCfzA-ThlhZEoJKZ-hCSMkzyTLixM0obksMyZleYrOQvhOSCH4jL5Ap5zzPC95OUH3K91APLzHF01jjTbppV2NlzpacBGvUgyNNtH2Dv-0cYsrZ6PVLV6Ct7steN22h5QM4CPUeJGaUgovdNxCBB_wou922qfSsfsm7FO1GqA7cP0-4LkxEAK2Dq_Bd9aNeu0g4Qz4x03CRzzH12m1vrO_ktpyqwPgqsKruK8PL9HzRrcBXj3Ec3RzebFefMmuvn6uFvOrzLCiKLMGgDFebBrJGakLLQpSbwQtmSAFJRsqcyKJZqyQG6mJaDTTNZMmHYvrkqWjnaN3o67zjbo1VvXaHuO3Xt16Nb9eV0qWQjA6S-ynkd3tNx3UZryM2nnbaX84dv5dcXabdO5UySSlUiSBtw8Cvv-xhxBVZ4OBttUO0uUUEzMuKGF8QN_8OetpyOM_JyAbAeP7EDw0TwglavCRSj5Sg4_U4KPE8394Y6MeXJBWte1_un4D7ajOQQ
CitedBy_id crossref_primary_10_1186_s12885_024_12099_8
crossref_primary_10_1177_10499091241252977
crossref_primary_10_17479_jacs_2024_14_1_9
crossref_primary_10_1007_s00520_021_06293_8
crossref_primary_10_1016_j_jpedsurg_2024_02_022
crossref_primary_10_3390_cancers15194712
crossref_primary_10_1177_10547738231194099
crossref_primary_10_1038_s41598_021_91749_4
crossref_primary_10_3390_cancers15041338
crossref_primary_10_5758_vsi_220054
crossref_primary_10_1007_s00520_024_08664_3
crossref_primary_10_1007_s00520_023_08045_2
crossref_primary_10_1177_10547738241260947
Cites_doi 10.4065/72.3.225
10.1007/s00520-016-3360-6
10.1007/s00520-005-0886-4
10.7326/0003-4819-132-5-200003070-00009
10.1111/j.1444-0903.2004.00447.x
10.1056/nejmra011883
10.1200/jco.2002.11.135
10.4143/crt.2013.148
10.1016/j.jpainsymman.2009.11.327
10.1089/sur.2008.058
10.1053/srao.2000.6590
10.14475/kjhpc.2014.17.3.179
10.1111/j.1365-2354.2006.00664.x
ContentType Journal Article
Copyright Copyright © 2021 by the Korean Cancer Association 2021
Copyright_xml – notice: Copyright © 2021 by the Korean Cancer Association 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.4143/crt.2020.1008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 888
ExternalDocumentID oai_kci_go_kr_ARTI_9844217
PMC8291194
33355838
10_4143_crt_2020_1008
Genre Randomized Controlled Trial
Clinical Trial, Phase II
Journal Article
GrantInformation_xml – fundername: Pusan National University Hospital
  grantid: 30-2017-004
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
M~E
ID FETCH-LOGICAL-c2668-fee2236bf9320d6a460db418240610b195090a2269b9a04fa2ad29c3353a82333
ISSN 1598-2998
2005-9256
IngestDate Tue Nov 21 21:35:44 EST 2023
Thu Aug 21 14:32:11 EDT 2025
Fri Jul 11 07:50:30 EDT 2025
Thu Apr 03 06:59:54 EDT 2025
Thu Apr 24 23:10:58 EDT 2025
Tue Jul 01 03:18:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Palliative care
Terminally ill cancer patients
Peripherally inserted central catheter
Language English
License This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2668-fee2236bf9320d6a460db418240610b195090a2269b9a04fa2ad29c3353a82333
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
This study was presented in part at the ESMO Virtual Congress 2020, 19 September–21 September 2020.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8291194
PMID 33355838
PQID 2473410234
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9844217
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8291194
proquest_miscellaneous_2473410234
pubmed_primary_33355838
crossref_primary_10_4143_crt_2020_1008
crossref_citationtrail_10_4143_crt_2020_1008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-Jul
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-Jul
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2021
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
ref12
ref14
ref11
ref10
ref2
ref1
ref8
ref7
ref9
ref4
ref3
Llobera (ref6) 2000
ref5
References_xml – start-page: 2036
  volume-title: Terminal cancer. duration and prediction of survival time
  year: 2000
  ident: ref6
– ident: ref3
  doi: 10.4065/72.3.225
– ident: ref7
  doi: 10.1007/s00520-016-3360-6
– ident: ref4
  doi: 10.1007/s00520-005-0886-4
– ident: ref14
  doi: 10.7326/0003-4819-132-5-200003070-00009
– ident: ref12
  doi: 10.1111/j.1444-0903.2004.00447.x
– ident: ref10
  doi: 10.1056/nejmra011883
– ident: ref2
  doi: 10.1200/jco.2002.11.135
– ident: ref5
  doi: 10.4143/crt.2013.148
– ident: ref9
  doi: 10.1016/j.jpainsymman.2009.11.327
– ident: ref11
  doi: 10.1089/sur.2008.058
– ident: ref1
  doi: 10.1053/srao.2000.6590
– ident: ref8
  doi: 10.14475/kjhpc.2014.17.3.179
– ident: ref13
  doi: 10.1111/j.1365-2354.2006.00664.x
SSID ssj0064371
Score 2.2025466
Snippet Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a...
The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 881
SubjectTerms Administration, Intravenous - adverse effects
Aged
Aged, 80 and over
Antineoplastic Agents - administration & dosage
Catheterization, Peripheral - adverse effects
Catheterization, Peripheral - psychology
Catheterization, Peripheral - statistics & numerical data
Female
Hospices - statistics & numerical data
Humans
Male
Middle Aged
Neoplasms - drug therapy
Neoplasms - psychology
Original
Palliative Care - methods
Palliative Care - psychology
Palliative Care - statistics & numerical data
Patient Satisfaction - statistics & numerical data
Prospective Studies
Terminal Care - methods
Terminal Care - psychology
Terminal Care - statistics & numerical data
Terminally Ill - psychology
Terminally Ill - statistics & numerical data
Treatment Outcome
의학일반
Title Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study
URI https://www.ncbi.nlm.nih.gov/pubmed/33355838
https://www.proquest.com/docview/2473410234
https://pubmed.ncbi.nlm.nih.gov/PMC8291194
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738775
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2021, 53(3), , pp.881-888
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9owFLZKK1V9mbo7u8mbpr1AupAYkuwNOqrC1A2tIPUtcoIpqDSpAmhq_9_-187xJRfUSVtfuORim5wP-xz783cI-SimPo9g5LO46HQsxmLXgj7Pxa_tOPIcXM1BtsX3zumEDS_aFzu1wxJrabOOjuK7e_eVPMSqcAzsirtk_8OyeaFwAD6DfeEVLAyv_2Tjcz4TStS_j0oQPL41ZMyRkkttnJc2L6g51wGyhcAuI2iglBRYLm-RMiCydTHZqzYGovCm6jBykvpktZHiHGvMWiTVXbsy4yJOm4wVr0aWt8QiAE-ZaclKbYH_CY1Lrxd3UN5oDgNoYzCQVMbK4rK-U-sQqa13OSG-WPNSJO_-JmkMN9tHv_1KkzSf6dYpo4dcWMO04B38mKs58eTS6qXl6Q-nlVNl9WaCNMMVC92wbUjrPj3AjSYq2fWRkMekAGvgKE1zMxAo1WINeLfUq_sqq4xxEFQewu2xh4HnCYCJM2ToOpJ-UrkOHvPNtQSi66KmvesXQ3BOjBydHfsOjD8Bq5E9x_OQebDX7X3tnRj3AhdalQiw_lVKOBZr_1yp-4Dsm4oqPlctyWb3hVPbrOCSmzU-JI90fES7CuyPyY5InpD9M80AeUp-K8w3qUF8kwI8qEYZLeOdImKpxjst450avFONd5rjnRq8q7sl3mkJ71ThnS4SWuCdAt6pAodpyeoL7dIC7VSinQ4GVKL9GZmc9MfHp5ZORWLF4MH61kwI8KM70QzCHXva4axjTyMGsTn6w3aEuZQDm0MoE0QBt9mMO3zqBDE8f5f7DtjhOdlN0kS8JDQCbxCiHDzXYj53olbMbBFz0fY5hGdxnTSNscJY6_RjuphlCPE6mjkEM4doZtQb9-vkU375jRKo-duFH8Dy4VW8CFFSHt8v0_AqCyFwHoSBz5jT8urkvQFGCOMMLh7yRMDTDR3mgcMLHj6rkxcKKHl9Bmd14lUglF-AFVbPJIu51LLXaH_14Dtfk4OiW3hDdtfZRryFOGEdvdP_nD8Eixi9
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety%2C+Efficacy%2C+and+Patient+Satisfaction+with+Initial+Peripherally+Inserted+Central+Catheters+Compared+with+Usual+Intravenous+Access+in+Terminally+Ill+Cancer+Patients%3A+A+Randomized+Phase+II+Study&rft.jtitle=Cancer+research+and+treatment&rft.au=Park%2C+Eun+Ju&rft.au=Park%2C+Kwonoh&rft.au=Kim%2C+Jae-Joon&rft.au=Oh%2C+Sang-Bo&rft.date=2021-07-01&rft.pub=Korean+Cancer+Association&rft.issn=1598-2998&rft.eissn=2005-9256&rft.volume=53&rft.issue=3&rft.spage=881&rft.epage=888&rft_id=info:doi/10.4143%2Fcrt.2020.1008&rft_id=info%3Apmid%2F33355838&rft.externalDocID=PMC8291194
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon